Loading…
Imunon, Inc. is projected to decline to $1.97 by 2027, a -3% move from its current price of $2.02. IMNN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $1.97 | $2.02 | $2.07 | +0.03% |
| Jul 13 | $1.95 | $2.02 | $2.09 | +0.06% |
| Jul 14 | $1.94 | $2.02 | $2.11 | +0.09% |
| Jul 15 | $1.92 | $2.02 | $2.13 | +0.12% |
| Jul 16 | $1.91 | $2.02 | $2.14 | +0.15% |
| Jul 17 | $1.90 | $2.02 | $2.15 | +0.18% |
| Jul 18 | $1.90 | $2.02 | $2.16 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.90 | $2.02 | $2.16 | +0.21% |
| Week 2 | $1.85 | $2.03 | $2.23 | +0.42% |
| Week 3 | $1.81 | $2.03 | $2.28 | +0.63% |
| Week 4 | $1.79 | $2.04 | $2.32 | +0.84% |
| Week 5 | $1.76 | $2.04 | $2.36 | +1.05% |
| Week 6 | $1.74 | $2.05 | $2.40 | +1.26% |
| Week 7 | $1.72 | $2.05 | $2.44 | +1.47% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Imunon, Inc. is a clinical-stage biotechnology company focused on developing immunotherapies and vaccines in the United States.
Its lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase 3 clinical trial for the localized treatment of advanced ovarian cancer, as well as in the IND-enabling phase for colorectal and pancreatic cancers, and in the discovery phase for glioblastoma.
The company is also developing IMNN-101, a COVID-19 booster vaccine that has completed a Phase 1 clinical trial. It also develops non-viral DNA technology across modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; and PlaCCine for the coding of viral antigens that can elicit a strong immunological response. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc.
in September 2022. Imunon, Inc. was incorporated in 1982 and is headquartered in Lawrenceville, New Jersey.
Imunon, Inc. trades under the symbol IMNN and is currently priced at $2.06. It has a market capitalization of $8.66M and a rank of 5154. The near-term price action is mixed, but the long-term outlook is bullish according to the forecast figures.
By 2030 the average price is $2.60 with a potential range to $3.72 and a forecasted ROI of 26.1, and sentiment is BULLISH. The 2040 and 2050 forecasts show further upside, with average prices of $3.36 (ROI 63.3) and $6.30 (ROI 205.7) respectively, both with a BULLISH sentiment.
A major floor 29.0% below — a decisive break under it would weaken the trend.
The nearest floor, 14.9% below — buyers have tended to step in here.
The nearest ceiling, 13.9% above — a clean break opens room to run.
A major ceiling 71.3% above — clearing it would confirm fresh momentum.
Key IMNN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IMNN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.00 | Buy | $1.99 | Buy |
| MA 10 | $1.92 | Buy | $1.95 | Buy |
| MA 20 | $1.89 | Buy | $1.96 | Buy |
| MA 50 | $2.19 | Sell | $2.18 | Sell |
| MA 100 | $2.62 | Sell | $2.64 | Sell |
| MA 200 | $3.36 | Sell | $3.89 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.93 | Neutral |
| Stoch RSI (14) | 91.27 | Sell |
| CCI (20) | 93.91 | Neutral |
| Williams %R (14) | -11.76 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 13.48 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 88.24 | Sell |
| TRIX (15) | -0.72 | Sell |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 70.85 | Sell |
| Momentum (10) | 0.30 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 2.06 | Sell |
| ADX (14) | 32.86 | Buy |
| ATR (14) | 0.05 | Info |
The current technical picture is NEUTRAL with RSI14 at 60. The stock trades with SMA50 at $2.22 and SMA200 at $3.39, placing resistance around $2.30 and support near $1.72. In the last 30 days the price has traded between $1.74 and $2.43.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.72 | $2.02 | $2.63 | 0% | Neutral | |
| $1.58 | $1.97 | $2.59 | -3% | Neutral | |
| $1.57 | $2.01 | $2.73 | -1% | Neutral | |
| $1.74 | $2.27 | $3.17 | +12% | Neutral | |
| $1.91 | $2.54 | $3.62 | +26% | Bullish | |
| $1.91 | $2.58 | $3.75 | +28% | Bullish | |
| $1.80 | $2.48 | $3.67 | +23% | Bullish | |
| $1.86 | $2.58 | $3.89 | +28% | Bullish | |
| $1.81 | $2.55 | $3.90 | +26% | Bullish | |
| $1.76 | $2.52 | $3.91 | +25% | Bullish | |
| $2.17 | $3.30 | $5.42 | +63% | Bullish | |
| $3.64 | $6.11 | $10.93 | +203% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.72 | $2.02 | $2.35 | +0.00% |
| August 2026 | $1.69 | $1.99 | $2.41 | -1.38% |
| September 2026 | $1.75 | $2.08 | $2.53 | +4.19% |
| October 2026 | $1.75 | $2.09 | $2.57 | +0.64% |
| November 2026 | $1.72 | $2.06 | $2.56 | -1.19% |
| December 2026 | $1.76 | $2.11 | $2.63 | +2.29% |
Click any year to see its month-by-month IMNN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect IMNN to range from $1.72 to $2.63 through 2026. The $2.02 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The IMNN price prediction for 2027 points to an average of $1.97 (low $1.58, high $2.59) — a potential decline of -3% on today's $2.02. Price action looks broadly range-bound.
In 2028, IMNN is projected to trade between $1.57 and $2.73, averaging $2.01 — a potential decline of -1% from today's $2.02. That is up +2% on the projected 2027 average. A consolidation phase looks the most probable path here.
Imunon, Inc.'s 2029 outlook centres on $2.27, within a $1.74 to $3.17 range. That is up +13% on the projected 2028 average. That marks a +12% change versus current levels. Price action looks broadly range-bound.
By 2030, IMNN could reach as high as $3.62, with a base case around $2.54 and support toward $1.91 — roughly +26% from $2.02. Buyers look set to stay in control over this stretch.
Expect IMNN to range from $1.91 to $3.75 through 2031. The $2.58 average target implies a +28% move from current prices. That is up +2% on the projected 2030 average. Momentum favours further upside here.
The IMNN price prediction for 2032 points to an average of $2.48 (low $1.80, high $3.67) — a potential gain of +23% on today's $2.02. Buyers look set to stay in control over this stretch.
In 2033, IMNN is projected to trade between $1.86 and $3.89, averaging $2.58 — a potential gain of +28% from today's $2.02. That is up +4% on the projected 2032 average. Momentum favours further upside here.
Imunon, Inc.'s 2034 outlook centres on $2.55, within a $1.81 to $3.90 range. That is -1% versus the projected 2033 average. That marks a +26% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, IMNN could reach as high as $3.91, with a base case around $2.52 and support toward $1.76 — roughly +25% from $2.02. Momentum favours further upside here.
Expect IMNN to range from $2.17 to $5.42 through 2040. The $3.30 average target implies a +63% move from current prices. That is up +31% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The IMNN price prediction for 2050 points to an average of $6.11 (low $3.64, high $10.93) — a potential gain of +203% on today's $2.02. Momentum favours further upside here.
Investing $1,000 in IMNN today (≈ 495.049505 IMNN) could be worth
$3,026.93
+$2,026.93 (+203%) by 2050 · US Dollar
Based on the average projected IMNN price of $6.11 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IMNNwould be worth at today's price.
$1,000 invested in IMNN on Jul 10, 2025 (≈ 117.948716 IMNN) would be worth
$238.26
-$761.74 (-76.2%) today · 0.24× · US Dollar
Based on a IMNN entry price of $8.48 vs. today's $2.02.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.91 | $1,057.59 | +5.8% |
| 1 month ago | $1.98 | $1,020.2 | +2.0% |
| 3 months ago | $2.92 | $691.78 | -30.8% |
| 6 months ago | $3.56 | $567.42 | -43.3% |
| 1 year ago | $8.48 | $238.26 | -76.2% |
| All time (5.0y) ago | $225 | $8.98 | -99.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IMNN forecast.
Our base-case forecast reaches $4.00 around 2050.
Implied market cap at $4.00: $16.81M
From 2030 onward the forecast shows a bullish regime, with an average price of $2.60, a minimum of $1.95 and a maximum of $3.72, yielding a forecasted ROI of 26.1 and a BULLISH sentiment. 2031 shows average $2.63, min $1.94, max $3.84, ROI 27.6, sentiment BULLISH. 2032 shows average $2.53, min $1.84, max $3.77, ROI 22.9, sentiment BULLISH.
2033 shows average $2.63, min $1.88, max $3.98, ROI 27.8, sentiment BULLISH. 2034 shows average $2.60, min $1.84, max $3.99, ROI 26.3, sentiment BULLISH. 2035 shows average $2.58, min $1.80, max $4.02, ROI 25.3, sentiment BULLISH.
2040 shows average $3.36, min $2.21, max $5.55, ROI 63.3, sentiment BULLISH. 2050 shows average $6.30, min $3.72, max $11.32, ROI 205.7, sentiment BULLISH. These figures illustrate a long-run bullish trajectory with increasing upside potential, while noting that forecasts are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $2.60, min $1.95, max $3.72; ROI 26.1; sentiment BULLISH.
The forecast turns bullish from 2030 onward, with average prices rising to $2.60 in 2030, $3.36 in 2040 and $6.30 in 2050, and ROI reaching 26.1, 63.3 and 205.7, respectively. The sentiment is BULLISH in these years, but forecasts are not guarantees.
Yes. The 2035 forecast shows a max of $4.02, with min $1.80 and average $2.58; ROI 25.3; sentiment BULLISH.
Current price $2.06; Market cap $8.66M; Rank 5154.
Avg $3.36, min $2.21, max $5.55; ROI 63.3; sentiment BULLISH.
Imunon, Inc. Community Discussion
0Share your Imunon, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.